|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Htg Molecular Diagnostics, Inc (HTGM) |
|
|
$0.28 0.00 (0.00%) as of 4:30 Fri 11/20
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
9,000,000 |
Market
Cap: |
2.56(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.2849 - $0.2849 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile HTG Molecular Diagnostics is a commercial stage RNA platform-based life sciences company focused on developing medicine. Co.'s product and service solutions are based on its digital HTG EdgeSeq technology that enables RNA profiling using a small amount of biological sample, in liquid or solid forms. Co. markets proprietary molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. Co.'s marketed panels include: HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq Precision Immuno-Oncology Panel; HTG Lung Fusions Assay; HTG Autoimmune Panel; HTG EdgeSeq Immuno-Oncology Assay; and HTG Mouse mRNA Tumor Response Panel.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
888 |
888 |
Total Sell Value |
$0 |
$0 |
$710 |
$710 |
Total People Sold |
0 |
0 |
1 |
1 |
Total Sell Transactions |
0 |
0 |
1 |
1 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Glaxosmithkline Plc |
Former 10% Owner |
|
2017-03-27 |
4 |
S |
$10.15 |
$3,045,180 |
I/I |
(300,000) |
792,781 |
|
- |
|
Lubniewski John L |
Chief Business Officer |
|
2016-12-09 |
4 |
A |
$1.83 |
$1,524 |
D/D |
834 |
46,789 |
|
- |
|
Johnson Tim B |
President & CEO |
|
2016-12-09 |
4 |
A |
$1.83 |
$1,524 |
D/D |
834 |
92,213 |
|
- |
|
Mcmeans Shaun D |
VP, Finance & Admin. & CFO |
|
2016-12-09 |
4 |
A |
$1.83 |
$1,524 |
D/D |
834 |
41,738 |
|
- |
|
Roche Patrick C. |
SVP Research & Development |
|
2016-12-09 |
4 |
A |
$1.83 |
$1,524 |
D/D |
834 |
40,914 |
|
- |
|
Gordon Debra A |
V.P. and Chief Legal Counsel |
|
2016-12-09 |
4 |
A |
$1.83 |
$1,524 |
D/D |
834 |
39,284 |
|
- |
|
Qiagen Nv |
10% Owner |
|
2016-11-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
833,333 |
|
- |
|
Roche Patrick C. |
SVP Research & Development |
|
2016-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
40,080 |
|
- |
|
Mcmeans Shaun D |
VP, Finance & Admin. & CFO |
|
2016-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
40,904 |
|
- |
|
Lubniewski John L |
Chief Business Officer |
|
2016-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
45,955 |
|
- |
|
Gordon Debra A |
V.P. and Chief Legal Counsel |
|
2016-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
38,450 |
|
- |
|
Johnson Tim B |
President & CEO |
|
2016-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
91,379 |
|
- |
|
Johnson Tim B |
President & CEO |
|
2016-06-10 |
4 |
A |
$2.54 |
$1,545 |
D/D |
608 |
51,379 |
|
- |
|
Roche Patrick C. |
SVP Research & Development |
|
2016-06-10 |
4 |
A |
$2.54 |
$2,359 |
D/D |
928 |
20,080 |
|
- |
|
Lubniewski John L |
Chief Business Officer |
|
2016-06-10 |
4 |
A |
$2.54 |
$2,359 |
D/D |
928 |
25,955 |
|
- |
|
Gordon Debra A |
V.P. and Chief Legal Counsel |
|
2016-06-10 |
4 |
A |
$2.54 |
$2,359 |
D/D |
928 |
18,450 |
|
- |
|
Mcmeans Shaun D |
VP, Finance & Admin. & CFO |
|
2016-06-10 |
4 |
A |
$2.54 |
$2,359 |
D/D |
928 |
20,904 |
|
- |
|
Mcmeans Shaun D |
VP, Finance & Admin. & CFO |
|
2016-04-04 |
4 |
AS |
$2.92 |
$512 |
D/D |
(175) |
19,976 |
|
- |
|
Lubniewski John L |
Chief Business Officer |
|
2016-04-04 |
4 |
AS |
$2.92 |
$254 |
D/D |
(87) |
25,027 |
|
- |
|
Johnson Tim B |
President & CEO |
|
2016-04-04 |
4 |
AS |
$2.92 |
$1,573 |
D/D |
(538) |
50,771 |
|
- |
|
Gordon Debra A |
V.P. and Chief Legal Counsel |
|
2016-04-04 |
4 |
AS |
$2.92 |
$535 |
D/D |
(183) |
17,522 |
|
- |
|
Mcmeans Shaun D |
VP, Finance & Admin. & CFO |
|
2016-04-01 |
4 |
AS |
$2.89 |
$4,119 |
D/D |
(1,426) |
20,151 |
|
- |
|
Lubniewski John L |
Chief Business Officer |
|
2016-04-01 |
4 |
AS |
$2.89 |
$2,048 |
D/D |
(709) |
25,114 |
|
- |
|
Johnson Tim B |
President & CEO |
|
2016-04-01 |
4 |
AS |
$2.89 |
$12,641 |
D/D |
(4,376) |
51,309 |
|
- |
|
Gordon Debra A |
V.P. and Chief Legal Counsel |
|
2016-04-01 |
4 |
AS |
$2.89 |
$4,301 |
D/D |
(1,489) |
17,705 |
|
- |
|
227 Records found
|
|
Page 7 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|